Salvage irreversible electroporation for radio‐recurrent prostate cancer – the prospective <scp>FIRE</scp> trial

Abstract

The FIRE trial shows that salvage IRE after failed radiation therapy for localised PCa is safe with minimal toxicity, and promising functional and oncological outcomes. Salvage IRE can offer a possible solution for notoriously difficult to manage radio recurrent prostate tumours.